Josh Enomoto

Josh Enomoto

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

9 Robust Stocks to Buy to Survive a Bear Market

With the markets providing many discounts, contrarians may just want to dive right in. However, going with the most well-rounded and relevant names could be the smarter choice.

2 Pros, 2 Cons for Investing in Moderna as It Develops Coronavirus Vaccine

With the world under seige from the coronavirus pandemic, an investment like MRNA stock appears incredibly relevant. Still, you should consider some risk factors before diving in.

Boeing Is Staring Down an Unprecedented Crisis

If you’re considering the contrarian case for Boeing stock, I’d consider looking elsewhere. Drilling into the details, this is a severely embattled investment.

Why 3M Is Now a Long-Term Investment

In our nation’s hour of need, accusations about profiteering leveled at 3M didn’t do the brand any good. However, MMM stock is still a relevant name in this pandemic – and even after it.

It’s Time to Pull Out of Wynn Stock While You Still Can

Due to positive news on the coronavirus front, Wynn stock might seem like a reasonable contrarian bet. Unfortunately, economic data suggests a much longer road to recovery than you might think.